| AEs | adverse events |
| CCK-BR | cholecystokinin B receptor |
| CTCAE | Common Terminology Criteria for Adverse Events |
| EMT | epithelial-to-mesenchymal transition |
| ER | epitope retrieval |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| GEEs | Generalized Estimating Equations |
| GEM-NAB-P | gemcitabine/nab-paclitaxel |
| GPCRs | G-protein-coupled receptors |
| MASH | metabolic dysfunction-associated steatohepatitis |
| H&E | hematoxylin and eosin |
| MPQ | McGill Pain Questionnaire |
| NK | natural killer |
| PDAC | pancreatic ductal adenocarcinoma |
| PSCs | pancreatic stellate cells |
| RT | room temperature |
| TAMs | tumor-associated macrophages |
| TID | three times daily |
| TILs | tumor-infiltrating lymphocytes |
| TME | tumor microenvironment |
| ULN | upper limit of normal |